Selegiline

What is Selegiline?

Selegiline is a pharmaceutical compound primarily known for its role as a selective, irreversible monoamine oxidase B (MAO-B) inhibitor. It belongs to a class of drugs that affect neurotransmitters in the brain. Originally developed as an antidepressant, its most recognized application today is in the management of Parkinson's disease. It is also approved in certain formulations for the treatment of major depressive disorder.

Monoamine oxidase B (MAO-B) is an enzyme found in the brain and other tissues that plays a crucial role in breaking down certain neurotransmitters, particularly dopamine. By inhibiting this enzyme, Selegiline helps to increase the levels of dopamine available in the brain, which is beneficial for conditions characterized by dopamine deficiency.

How Does it Work?

The primary mechanism of action of Selegiline involves its selective and irreversible inhibition of the MAO-B enzyme. In the brain, MAO-B is responsible for the catabolism (breakdown) of dopamine. By blocking MAO-B, Selegiline prevents dopamine from being broken down, leading to higher and more sustained levels of dopamine in the synaptic clefts.

For patients with Parkinson's disease, who experience a progressive loss of dopamine-producing neurons, increasing dopamine availability can significantly improve motor symptoms such as tremor, rigidity, and bradykinesia. At lower, therapeutic doses, Selegiline's inhibition is highly selective for MAO-B, meaning it does not significantly inhibit MAO-A, another form of the enzyme responsible for breaking down other neurotransmitters like serotonin and norepinephrine.

Beyond its impact on dopamine levels, some research suggests that Selegiline may also possess neuroprotective properties, potentially slowing the progression of neurodegenerative diseases, though this remains an area of ongoing study. For the treatment of depression, particularly when administered via a transdermal patch, higher systemic levels of Selegiline can lead to some inhibition of MAO-A as well, contributing to its antidepressant effects.

Medical Uses

• Parkinson's Disease

  Selegiline is widely used in the treatment of early-stage Parkinson's disease, either as monotherapy or as an adjunct to levodopa therapy. When used alone, it can help delay the need for levodopa by improving symptoms. When combined with levodopa, it can enhance levodopa's effects, reduce its necessary dosage, and potentially extend the duration of its benefits, helping to manage “wearing-off” phenomena and “on-off” fluctuations. It is particularly useful in managing motor fluctuations and improving overall quality of life for Parkinson's patients.

• Major Depressive Disorder

  A transdermal patch formulation of Selegiline is approved for the treatment of major depressive disorder in adults. This delivery method allows for higher systemic absorption while minimizing gut MAO-A inhibition, which can reduce the risk of dietary tyramine interactions typically associated with non-selective MAO inhibitors. It offers an alternative for patients who have not responded to other antidepressant treatments.

Dosage

The dosage of Selegiline varies significantly depending on the condition being treated and the formulation used. It is crucial to always follow your healthcare provider's instructions.

• For Parkinson's Disease (Oral Tablets): The typical dose is 5 mg administered twice daily, usually with breakfast and lunch. Doses higher than 10 mg per day generally do not provide additional benefit and may increase the risk of side effects.
• For Major Depressive Disorder (Transdermal Patch): The starting dose is usually 6 mg/24 hours, applied once daily to a clean, dry area of skin. The dose may be increased by your doctor to 9 mg/24 hours or 12 mg/24 hours if needed, based on response and tolerability.

It is important not to exceed recommended dosages, as this can lead to a loss of MAO-B selectivity and increase the risk of severe drug interactions and side effects.

Side Effects

Like all medications, Selegiline can cause side effects, though not everyone experiences them. Common side effects often include:

• Nausea and vomiting
• Insomnia or difficulty sleeping
• Dizziness or lightheadedness, especially when standing up (orthostatic hypotension)
• Dry mouth
• Abdominal pain
• Headache
• Confusion or hallucinations (more common in elderly patients or those also taking levodopa)
• Dyskinesia (involuntary movements), especially when used with levodopa, which may require a reduction in levodopa dosage.

More serious, but less common, side effects can include severe hypertension, cardiac arrhythmias, and the potential for serotonin syndrome when combined with certain other medications.

Drug Interactions

Due to its MAO-B inhibitory action, Selegiline has several important drug interactions that patients and healthcare providers must be aware of to prevent serious adverse events.

• Antidepressants: Concomitant use with selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), and other MAO inhibitors can lead to serotonin syndrome, a potentially life-threatening condition characterized by agitation, hallucinations, rapid heart rate, fever, and severe changes in blood pressure. A washout period is often required when switching between these medications.
• Opioids: Concurrent use with meperidine (Demerol) is absolutely contraindicated due to the risk of severe reactions, including hyperthermia, rigidity, and mental status changes. Other opioids should also be used with caution.
• Sympathomimetic Amines: Drugs like pseudoephedrine, ephedrine, and stimulants (e.g., methylphenidate, amphetamines) can cause hypertensive crises when combined with Selegiline, especially at higher doses where MAO-A inhibition may occur.
• Dextromethorphan: Found in many cough and cold remedies, dextromethorphan can interact with Selegiline to cause serotonin syndrome.
• Tyramine-Rich Foods: While highly selective MAO-B inhibition at low oral doses (10 mg/day or less) generally does not necessitate strict dietary restrictions, higher oral doses or the transdermal patch (which achieves higher systemic levels) may carry a risk of hypertensive crisis if large amounts of tyramine-rich foods (e.g., aged cheeses, cured meats, fermented products) are consumed. Patients should discuss dietary restrictions with their doctor.

FAQ

• Is Selegiline a controlled substance?

  No, Selegiline is not classified as a controlled substance in most countries, but it is a prescription-only medication.

• How long does Selegiline take to work?

  For Parkinson's disease, patients may start to experience benefits within a few weeks, but the full therapeutic effect can take several months to become apparent. For depression, effects from the transdermal patch may be noticed within 1-2 weeks, with full antidepressant effects often taking 4-6 weeks.

• Can Selegiline be stopped suddenly?

  It is generally not recommended to stop Selegiline suddenly, especially if you have been taking it for an extended period or for depression. Abrupt discontinuation can lead to withdrawal symptoms or a worsening of your underlying condition. Always consult your doctor before making any changes to your medication regimen.

• What foods should I avoid with Selegiline?

  At standard oral doses for Parkinson's disease (5-10 mg/day), strict dietary restrictions for tyramine-rich foods are usually not necessary due to the selectivity for MAO-B. However, if you are on higher doses, or using the transdermal patch for depression, or if your doctor advises it, you may need to limit foods high in tyramine. Always follow your doctor's specific dietary advice.

Products containing Selegiline are available through trusted online pharmacies. You can browse Selegiline-based medications at ShipperVIP or Medicenter.

Summary

Selegiline is an important medication primarily used in the management of Parkinson's disease and, in a transdermal formulation, for major depressive disorder. Its mechanism as a selective MAO-B inhibitor helps to increase dopamine levels in the brain, alleviating motor symptoms in Parkinson's and contributing to antidepressant effects. While generally well-tolerated, it is crucial to be aware of its potential side effects and, most importantly, its significant drug interactions, particularly with other antidepressants and certain pain medications. Always use Selegiline under the guidance of a healthcare professional, adhering strictly to prescribed dosages and reporting any adverse effects or concerns.